Pneumolysin: A multifunctional pneumococcal virulence factor

被引:54
|
作者
Rubins, JB
Janoff, EN
机构
[1] Univ Minnesota, Sch Med, Vet Affairs Med Ctr, Pulm Sect, Minneapolis, MN 55417 USA
[2] Univ Minnesota, Sch Med, Vet Affairs Med Ctr, Infect Dis Sect, Minneapolis, MN 55417 USA
来源
关键词
D O I
10.1016/S0022-2143(98)90073-7
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Pneumolysin (PLY) is a multifunctional pneumococcal virulence factor that appears to augment intrapulmonary growth and dissemination during the early pathogenesis of Streptococcus pneumoniae infection. Through its cytotoxicity to respiratory epithelium and endothelium, PLY disrupts pulmonary tissue barriers that serve as mechanical pulmonary defenses, thus facilitating S. pneumoniae growth and dissemination. Through direct inhibitory effects on immune and inflammatory cells and by activating complement, PLY inhibits bacterial clearance from the pulmonary interstitium and the blood. Because PLY stimulates local and systemic immune responses and enhances the immunogenicity of S. pneumoniae polysaccharide (PS), PLY-PS conjugates may form the basis for vaccines that not only induce protective and durable immune responses to pneumococcal PS but also generate neutralizing anti-PLY antibodies that can protect the respiratory mucosa from toxin-induced injury.
引用
收藏
页码:21 / 27
页数:7
相关论文
共 50 条
  • [41] Impact of Endogenous Pneumococcal Hydrogen Peroxide on the Activity and Release of Pneumolysin
    Bazant, Jasmin
    Ott, Benjamin
    Hudel, Martina
    Hain, Torsten
    Lucas, Rudolf
    Abu Mraheil, Mobarak
    TOXINS, 2023, 15 (10)
  • [42] Fusion of PspA to detoxified pneumolysin enhances pneumococcal vaccine coverage
    Milani, Barbara
    dos Santos, Tanila Wood
    Guerra, Maria Eduarda Souza
    Oliveira, Sheila
    Goulart, Cibelly
    Andre, Greiciely O.
    Leite, Luciana C. C.
    Converso, Thiago R.
    Darrieux, Michelle
    PLOS ONE, 2023, 18 (12):
  • [43] MAPPING OF IMMUNOREACTIVE SITES OF PNEUMOCOCCAL PNEUMOLYSIN BY USE OF SYNTHETIC PEPTIDES
    SALO, P
    NARVANEN, A
    LEINONEN, M
    INFECTION AND IMMUNITY, 1993, 61 (07) : 2822 - 2826
  • [44] DIAGNOSIS OF PNEUMOCOCCAL PNEUMONIA BY ENZYME-LINKED-IMMUNOSORBENT-ASSAY OF ANTIBODIES TO PNEUMOCOCCAL HEMOLYSIN (PNEUMOLYSIN)
    KALIN, M
    KANCLERSKI, K
    GRANSTROM, M
    MOLLBY, R
    JOURNAL OF CLINICAL MICROBIOLOGY, 1987, 25 (02) : 226 - 229
  • [45] Morin Moderates the Biotoxicity of Pneumococcal Pneumolysin by Weakening the Oligomers' Formation
    Zhao, Xiaoran
    Zhou, Yonglin
    Wang, Guizhen
    Shi, Dongxue
    Zha, Yonghong
    Yi, Pengfei
    Wang, Jianfeng
    CHEMICAL & PHARMACEUTICAL BULLETIN, 2017, 65 (06) : 538 - 544
  • [46] Preclinical evaluation of a chemically detoxified pneumolysin as pneumococcal vaccine antigen
    Hermand, Philippe
    Vandercammen, Annick
    Mertens, Emmanuel
    Di Paolo, Emmanuel
    Verlant, Vincent
    Denoel, Philippe
    Godfroid, Fabrice
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2017, 13 (01) : 220 - 228
  • [47] A pivotal role for pneumolysin in the immunopathogenesis, treatment and prevention of pneumococcal disease
    Feldman, Charles
    Anderson, Ronald
    SAMJ SOUTH AFRICAN MEDICAL JOURNAL, 2007, 97 (11): : 1141 - 1145
  • [48] Natural development of antibodies to pneumococcal surface protein A, pneumococcal surface adhesin A, and pneumolysin in relation to pneumococcal carriage and acute otitis media
    Rapola, S
    Jäntti, V
    Haikala, R
    Syrjänen, R
    Carlone, GM
    Sampson, JS
    Briles, DE
    Paton, JC
    Takala, AK
    Kilpi, TM
    Käyhty, H
    JOURNAL OF INFECTIOUS DISEASES, 2000, 182 (04): : 1146 - 1152
  • [49] Clinical outcome of acute pneumococcal otitis media and serum antibody responses to pneumococcal pneumolysin and polysaccharides in children
    Jero, J
    Virolainen, A
    Karma, P
    ACTA OTO-LARYNGOLOGICA, 2000, : 63 - 66
  • [50] Pneumolysin is a key factor in misidentification of macrolide-resistant Streptococcus pneumoniae and is a putative virulence factor of S-mitis and other streptococci
    Neeleman, C
    Klaassen, CHW
    Klomberg, DM
    de Valk, HA
    Mouton, JW
    JOURNAL OF CLINICAL MICROBIOLOGY, 2004, 42 (09) : 4355 - 4357